glp-1 and alcohol cravings A preliminary study of the physiological perceptual effects of receptor agonists during consumption in people with obesity glp-1 alcohol reduction GLP‐1 Receptor

Some people experience a weight loss plateau on GLP-1 medications

found that liraglutide, an GLP-1R agonists, reduces the activated microglia load in the cortex and dentate gyrus region of hippocampus, and the activated astrocyte load in the cortex

That discovery provided the genetic blueprint for a synthetic version called exenatide, marketed as Byetta, which was approved in 2005 as a treatment for type 2 diabetes. Ozempic was developed as a newer synthetic drug that mimics GLP-1, inspired by the discovery of exendin-4 in Gila Monster saliva

When undergoing GLP-1 therapy, keeping tabs on several health metrics is crucial for tracking progress and maintaining overall well-being